tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports
Want to see NGEN full AI Analyst Report?

NervGen Pharma (NGEN) Financial Statements

129 Followers

NervGen Pharma Financial Overview

NervGen Pharma's market cap is currently $250.53M. The company's EPS TTM is $-0.8457; its P/E ratio is -8.41; NervGen Pharma is scheduled to report earnings on August 13, 2026, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ -83.74KC$ -145.01KC$ -114.10KC$ -42.95K
Operating IncomeC$ -25.08MC$ -24.92MC$ -17.78MC$ -22.82MC$ -12.91M
EBITDAC$ -5.65MC$ -23.91MC$ -22.24MC$ -19.92MC$ -12.78M
Net IncomeC$ -44.12MC$ -23.99MC$ -22.38MC$ -20.54MC$ -12.82M
Balance Sheet
Cash & Short-Term InvestmentsC$ 22.07MC$ 17.35MC$ 11.66MC$ 22.25MC$ 17.06M
Total AssetsC$ 23.21MC$ 19.47MC$ 13.24MC$ 23.67MC$ 18.03M
Total DebtC$ 8.37KC$ 105.53KC$ 197.21KC$ 280.96KC$ 0.00
Net DebtC$ -22.06MC$ -17.15MC$ -11.46MC$ -21.97MC$ -17.06M
Total LiabilitiesC$ 19.73MC$ 16.90MC$ 15.25MC$ 10.32MC$ 1.09M
Stockholders' EquityC$ 3.48MC$ 2.57MC$ -2.01MC$ 13.34MC$ 16.95M
Cash Flow
Free Cash FlowC$ -19.50MC$ -16.83MC$ -11.30MC$ -17.65MC$ -8.33M
Operating Cash FlowC$ -19.50MC$ -16.83MC$ -11.30MC$ -17.63MC$ -8.33M
Investing Cash FlowC$ 100.93KC$ 58.83KC$ -138.87KC$ -20.92KC$ -45.43K
Financing Cash FlowC$ 23.76MC$ 22.68MC$ 766.35KC$ 22.44MC$ 19.76M
Currency in CAD

NervGen Pharma Earnings and Revenue History

Income Statement >

NervGen Pharma Debt to Assets

Balance Sheet >

NervGen Pharma Cash Flow

Cash Flow >

NervGen Pharma Forecast EPS vs Actual EPS

Earnings >